id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0094-0022,FDA,FDA-2002-D-0094,"Appendix A - "" RJReynolds Letter to FDA, June 30, 2010"" - [R.J. Reynolds Tobacco Company - Comment] re FDA-2002-D-0094-0018",Supporting & Related Material,C-Comment (Supporting and Related Material),2010-11-05T04:00:00Z,2010,11,,,2012-03-24T19:34:22Z,,0,0,0900006480b6d38d
FDA-2002-D-0094-0023,FDA,FDA-2002-D-0094,"Appendix C - ""FDAAC August 30, 2010"" - [R.J. Reynolds Tobacco Company - Comment] re FDA-2002-D-0094-0018",Supporting & Related Material,C-Comment (Supporting and Related Material),2010-11-05T04:00:00Z,2010,11,,,2010-11-05T21:04:14Z,,0,0,0900006480b82f6d
FDA-2002-D-0094-0007,FDA,FDA-2002-D-0094,"Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers; Availability",Notice,NAD-Notice of Availability of Data,2010-04-22T04:00:00Z,2010,4,2010-04-22T04:00:00Z,2010-06-22T03:59:59Z,2010-04-22T14:20:21Z,2010-09313,0,0,0900006480add0fe
FDA-2002-D-0094-0008,FDA,FDA-2002-D-0094,"Guidance for the Public, Food and Drug Administration Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers; Draft Guidance",Other,GDL-Guidance (Supporting and Related Materials),2010-04-22T04:00:00Z,2010,4,2010-04-22T04:00:00Z,2010-06-22T03:59:59Z,2024-11-12T04:51:25Z,,1,0,0900006480add437